The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2025

Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1698978

No of Pages : 92

Ask Your Query

Synopsis

Market Analysis and Insights: Global Peripheral Parenteral Nutrition (PPN) Market
The global Peripheral Parenteral Nutrition (PPN) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Carbohydrates accounting for % of the Peripheral Parenteral Nutrition (PPN) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Peripheral Parenteral Nutrition (PPN) market size is valued at US$ million in 2021, while the North America and Europe Peripheral Parenteral Nutrition (PPN) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Peripheral Parenteral Nutrition (PPN) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Parenteral Nutrition (PPN) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Parenteral Nutrition (PPN) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Parenteral Nutrition (PPN) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Parenteral Nutrition (PPN) market.

Global Peripheral Parenteral Nutrition (PPN) Scope and Market Size
Peripheral Parenteral Nutrition (PPN) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Peripheral Parenteral Nutrition (PPN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins and Minerals

Segment by Application

  • Hospital
  • Home

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Eurofarma
  • Corporacion De Laboratorios Farmaceuticos
  • Baxter International Inc.
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • Laboratorios Biogalenic
  • Laboratorios Finlay
  • Grifols International
  • Fresenius Kabi
  • Sichuan Kelun Pharmaceutical
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Home
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2017-2028)
2.2 Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
2.2.1 Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2017-2022)
2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2023-2028)
2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2017-2022)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2017-2022)
3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2021
3.5 Peripheral Parenteral Nutrition (PPN) Key Players Head office and Area Served
3.6 Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2017-2022)
4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2023-2028)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2017-2022)
5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
6.2 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Detail
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Detail
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Detail
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Detail
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Detail
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Detail
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Detail
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Detail
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Detail
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Detail
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Detail
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Carbohydrates
Table 3. Key Players of Parenteral Lipid Emulsion
Table 4. Key Players of Single Dose Amino Acid Solution
Table 5. Key Players of Trace Elements
Table 6. Key Players of Vitamins and Minerals
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2017-2022)
Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2023-2028)
Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2017-2022)
Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2021)
Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
Table 24. Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2017-2022)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2023-2028)
Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2017-2022)
Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2023-2028)
Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Eurofarma Company Detail
Table 45. Eurofarma Business Overview
Table 46. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
Table 47. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 48. Eurofarma Recent Development
Table 49. Corporacion De Laboratorios Farmaceuticos Company Detail
Table 50. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 51. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
Table 52. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 53. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 54. Baxter International Inc. Company Detail
Table 55. Baxter International Inc. Business Overview
Table 56. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
Table 57. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 58. Baxter International Inc. Recent Development
Table 59. Kelun Pharma Company Detail
Table 60. Kelun Pharma Business Overview
Table 61. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
Table 62. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 63. Kelun Pharma Recent Development
Table 64. B. Braun Company Detail
Table 65. B. Braun Business Overview
Table 66. B. Braun Peripheral Parenteral Nutrition (PPN) Product
Table 67. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 68. B. Braun Recent Development
Table 69. Fresenius Company Detail
Table 70. Fresenius Business Overview
Table 71. Fresenius Peripheral Parenteral Nutrition (PPN) Product
Table 72. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 73. Fresenius Recent Development
Table 74. Teva Pharmaceutical Industries Company Detail
Table 75. Teva Pharmaceutical Industries Business Overview
Table 76. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
Table 77. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 78. Teva Pharmaceutical Industries Recent Development
Table 79. Pfizer (Hospira) Company Detail
Table 80. Pfizer (Hospira) Business Overview
Table 81. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
Table 82. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 83. Pfizer (Hospira) Recent Development
Table 84. Ostuka Pharmaceutical Company Detail
Table 85. Ostuka Pharmaceutical Business Overview
Table 86. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 87. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 88. Ostuka Pharmaceutical Recent Development
Table 89. Laboratorios Biogalenic Company Detail
Table 90. Laboratorios Biogalenic Business Overview
Table 91. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
Table 92. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 93. Laboratorios Biogalenic Recent Development
Table 94. Laboratorios Finlay Company Detail
Table 95. Laboratorios Finlay Business Overview
Table 96. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN)Product
Table 97. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 98. Laboratorios Finlay Recent Development
Table 99. Grifols International Company Detail
Table 100. Grifols International Business Overview
Table 101. Grifols International Peripheral Parenteral Nutrition (PPN)Product
Table 102. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 103. Grifols International Recent Development
Table 104. Fresenius Kabi Company Detail
Table 105. Fresenius Kabi Business Overview
Table 106. Fresenius Kabi Peripheral Parenteral Nutrition (PPN)Product
Table 107. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 108. Fresenius Kabi Recent Development
Table 109. Sichuan Kelun Pharmaceutical Company Detail
Table 110. Sichuan Kelun Pharmaceutical Business Overview
Table 111. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN)Product
Table 112. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
Table 113. Sichuan Kelun Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2021 VS 2028
Figure 2. Carbohydrates Features
Figure 3. Parenteral Lipid Emulsion Features
Figure 4. Single Dose Amino Acid Solution Features
Figure 5. Trace Elements Features
Figure 6. Vitamins and Minerals Features
Figure 7. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Home Case Studies
Figure 10. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2021 VS 2028
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2021
Figure 15. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2021
Figure 17. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
Figure 19. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
Figure 23. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2017-2028)
Figure 31. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
Figure 39. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
Figure 43. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 46. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 47. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 48. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 49. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 50. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 52. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 53. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 54. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 55. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 56. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 57. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 58. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock